Monopar Therapeutics Inc. (MNPR)

SEC filing

Monopar Therapeutics Inc.

MNPR · CIK 1645469

4 · Sep 28, 2026 · Director, Chief Executive Officer Robinson Chandler sold 29.06K shares at $88.00/share ($2.6M); exercised options for 58.11K shares

Director, Chief Executive Officer Robinson Chandler sold 29.06K shares at $88.00/share ($2.6M); exercised options for 58.11K shares

Filed: Sep 28, 2026
Period: Sep 24, 2026
Accession: 0001437749-26-031411
Filer: Monopar Therapeutics (0001645469) (Issuer)

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4rdgdoc.xml
Open SEC.gov